Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Different rheumatological diseases can cause specific skin problems.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Anti-SRP myopathy can be linked to systemic lupus erythematosus and may improve with specific treatment.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Lupus can cause hair loss and nail changes, with treatments available for both.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Effective management of blood issues in SLE requires tailored treatments.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Early diagnosis and quick treatment are crucial for severe lupus cases.